The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma

[1] Ritch R(2001)Exfoliation syndrome Surv Ophthalmol 45 265-315

[2] Schlötzer-Schrehardt U(2000)Exfoliation syndrome and exfoliation glaucoma Prog Retin Eye Res 19 345-368

[3] Vesti E(1999)A three month, parallel, randomized, observer-masked, multicenter study comparing Cosopt™ to Xalatan™ in patients with elevated IOP Invest Ophthalmol Vis Sci 40 S665-20

[4] Kivela T(2001)A comparison of the efficacy and safety of latanoprost 0.005% every evening versus timolol/dorzolamide fixed combination twice daily Invest Ophthalmol Vis Sci 42 S420-185

[5] Fechtner R(1999)Comparison of the 24 hour intraocular pressure reduction with two dosing regimes of latanoprost and timolol in patients with open-angle glaucoma Am J Ophthalmol 128 15-627

[6] Clineschmidt C(1997)Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma Arch Ophthalmol 115 182-1145

[7] Getson A(1996)The impact of entry criteria on the baseline IOP in glaucoma studies: a meta-analysis Invest Ophthalmol Vis Sci 37 S1099-716

[8] Adamsons I(1993)Prevalence, diagnostic features, and response to trabeculectomy in exfoliation glaucoma Ophthalmology 100 619-402

[9] Konstas AGP(2001)From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture Invest Ophthalmol Vis Sci 42 1134-34

[10] Papapanos P(1989)Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F Exp Eye Res 48 707-1304

[1] Ritch R(2001)Exfoliation syndrome Surv Ophthalmol 45 265-315

[2] Schlötzer-Schrehardt U(2000)Exfoliation syndrome and exfoliation glaucoma Prog Retin Eye Res 19 345-368

[3] Vesti E(1999)A three month, parallel, randomized, observer-masked, multicenter study comparing Cosopt™ to Xalatan™ in patients with elevated IOP Invest Ophthalmol Vis Sci 40 S665-20

[4] Kivela T(2001)A comparison of the efficacy and safety of latanoprost 0.005% every evening versus timolol/dorzolamide fixed combination twice daily Invest Ophthalmol Vis Sci 42 S420-185

[5] Fechtner R(1999)Comparison of the 24 hour intraocular pressure reduction with two dosing regimes of latanoprost and timolol in patients with open-angle glaucoma Am J Ophthalmol 128 15-627

[6] Clineschmidt C(1997)Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma Arch Ophthalmol 115 182-1145

[7] Getson A(1996)The impact of entry criteria on the baseline IOP in glaucoma studies: a meta-analysis Invest Ophthalmol Vis Sci 37 S1099-716

[8] Adamsons I(1993)Prevalence, diagnostic features, and response to trabeculectomy in exfoliation glaucoma Ophthalmology 100 619-402

[9] Konstas AGP(2001)From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture Invest Ophthalmol Vis Sci 42 1134-34

[10] Papapanos P(1989)Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F Exp Eye Res 48 707-1304